US EditionFirestone Capital Management Invests $542,000 in Abbott Laboratories (NYSE:ABT)
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Firestone Capital Management Invests $542,000 in Abbott Laboratories (NYSE:ABT)
Firestone Capital Management bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 4,085 shares of the healthcare product maker’s stock, valued at approximately $542,000. A number of other hedge funds and other institutional […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
